Sep 2026· Expert Review of Vaccines· Vol 25 1, pp.
2735166
· 0 citations· 28 references
Medicine
TL;DR
Fatigue and functional performance improved over time regardless of vaccination status, and there was no statistically significant association between mRNA SARS-CoV-2 vaccination and worsening symptoms or impaired recovery.
Abstract
Background
Patients with post-acute sequelae of SARS-CoV-2 (PASC) fear SARS-CoV-2 vaccine-linked symptom aggravation. Data on objective functional outcomes are limited.
Methods
We performed a retrospective analysis of an observational cohort at a post-COVID outpatient clinic at Hannover Medical School with standardized assessments at baseline and follow-up visit (3-6 months) in adults with confirmed SARS-CoV-2 infection and PASC. Participants were classified as vaccination (receipt of an additional SARS-CoV-2 vaccine dose between visits) or no vaccination. Primary outcomes were fatigue (Fatigue Assessment Scale) and exercise capacity (6-minute walk distance). Propensity scores matching (1:1 nearest-neighbor, ATT; caliper 0.2 SD) was performed using logistic regression. Group differences were assessed using t-tests/χ2 tests with Benjamini-Hochberg adjustment. Longitudinal changes were analyzed using linear mixed-effects models.
Results
Of 193 eligible patients, 174 were analyzed, 148 remained after matching (74 per group). No significant differences between the groups were observed at baseline or follow-up after adjustment for multiple comparisons. Both groups improved over time, with no statistically significant difference in fatigue or exercise capacity.
Conclusions
Fatigue and functional performance improved over time regardless of vaccination status. We found no statistically significant association between mRNA SARS-CoV-2 vaccination and worsening symptoms or impaired recovery, although smaller effects cannot be excluded.
Background: Immunocompromised patients are at heightened risk for severe COVID-19 and its complications. While vaccination is critical for this population, long-term adherence and the durability of vaccine-induced immunity remain significant public health concerns. This study aimed to evaluate the longitudinal serologi...
A. Sarcone, Maria Rosaria Deodato, A. De Pasquale et al.· Vaccines· 0 citations
COVID-19 immune responses differ between children and adults, with adolescents exhibiting stronger immune response to vaccination than children younger than 12, however vaccine dosage may play a role in this observed difference.
Brooke A. Hawkes, J. Hollister, Cynthia Porter et al.· PLoS ONE· 0 citations
Post-COVID-19 condition (PCC) can persist for years after acute SARS-CoV-2 infection, but factors associated with long-term persistence and functional outcomes remain incompletely understood. In this longitudinal cohort study, adults with confirmed SARS-CoV-2 infection who had volunteered for plasma donation completed...
M. Faraj, A. Grosshennig, N. Goedecke et al.· Scientific Reports· 0 citations
Older adults had lower HR-QoL across multiple domains, whereas younger participants showed lower HR-QoL primarily during the early post-infection period, whereas younger participants showed lower HR-QoL primarily during the early post-infection period.
Zhi-Lian Huang, Alexius Matthias Se Soh, Kang-Wei Zeng et al.· Journal of Infection and Pub...· 0 citations
Early after household exposure, binding and neutralising antibodies were similar in all participants, but differences in T-cell functional responses were evident in individuals who developed symptoms after SARS-CoV-2 infection.
Christopher Kandel, Jessica A. Breznik, Maureen Taylor et al.· The Lancet Microbe· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.